This classification correlates with the PD, given that carriers of severe GBA mutations have a higher risk than those who have mild GBA mutations carriers (Brockmann et al., 2015; Sanchez-Martinez et al., 2016). This evidence concerns the gene GBA1 and Parkinson disease.